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Abstract
Background: Infections caused by Nocardia farcinica are uncommon and show a great variety of
clinical manifestations in immunocompetent and immunocompromised patients. Because of its
unspecific symptoms and tendency to disseminate it may mimic the clinical symptoms and
radiologic findings of a tumour disease and the diagnosis of nocardiosis can easily be missed,
because there are no characteristic symptoms.
Case presentation: We present a case of an adrenal gland abscess caused by subacute
disseminated N. farcinica pneumonia.
Conclusion:  An infection with N. farcinica is potentially lethal because of its tendency to
disseminate -particularly in the brain- and its high resistance to antibiotics. Awareness of this
differential diagnosis allows early and appropriate treatment to be administered.
Background
Nocardia species are aerobic, gram positive, filamentous,
weakly acid-fast bacteria which grow worldwide in soils as
well as animal tissues. There are more than eighty N. spe-
cies described until now [1], thereof one-half are recog-
nized as pathogens in humans or animals [2,3]. In recent
years because of the use of molecular techniques the tax-
onomy of Nocardia has been revised extensively [2-5].
An infection with N. farcinica is potentially lethal because
of its tendency to disseminate and its resistance to antibi-
otics [6-9]. N. farcinica is one of the prevalent species caus-
ing nocardiosis [10].
Definite rates of pulmonary N. farcinica infections are not
known, but might not be as rare as generally assumed.
Some reports indicate an increasing incidence because of
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a higher rate of immunodeficient patients, as well as
improved techniques to identify the bacteria [11].
Most of the symptomatic patients with pulmonary nocar-
diosis have a predisposing immunocomprimising disease
such as malignancies, advanced HIV infection, diabetes
mellitus, renal dysfunction, collagen vascular diseases,
alcoholism, tuberculosis, preceding operations, chronic
obstructive pulmonary disease (COPD), trauma or abnor-
mal phagocytic activity and medical immunosupression
e.g. steroid therapy [3]. In 15% of the cases it occurs with-
out underlying illness [6,12].
The patient presented in this case had no obvious immu-
nodeficiency. Possibly the combination of an alcoholic
toxicomania in the past (without any signs of liver dis-
ease) and the decreased general condition and nutritional
status have made the patient susceptible for the infection.
An extensive Japanese study showed that most of the
patients are between 60 and 80 years old [12] and some
authors state, that it occurs three times more often in men
than in women [6,13,14].
Nocardiosis is usually acquired through the lung, but also
by inoculation through traumatic injury of the integu-
ment [6,13,15]. Although health care-associated transmis-
sion has been documented, human-to-human
transmission of nocardiosis is considered to be improba-
ble [2,3,16]. It possibly metastasizes hematogenously into
distant organs, especially the brain, followed by kidney,
joints, bones and eyes [6,17]. Involvement of other organs
like adrenal gland is less common [18-21].
Nocardiosis is a microbiological diagnosis. N. farcinica
can be isolated in clinical specimen like pus, sputum,
bronchial secretion, biopsies, blood and urine in many
culture media after two to 14 days [22]. Because of the
potentially long culture time it is very important, that the
physicians notify the laboratory when Nocardia  is sus-
pected in a clinical specimen. One of the most important
findings is the presentation of the typical morphology of
N. species surrounded by acute inflammatory cells on a
direct Gram-stained smear [2]. Determination of the iden-
tification of the N. species via biochemical and/or molecu-
lar methods (which is the most reliable method for
identification) and of course the antimicrobial suscepti-
bility profile is important for the treatment of the patient
[23].
When pulmonary nocardiosis is diagnosed, a CT or MRT
of the brain and abdomen should be considered.
Therapy of the disease depends -beside the species and its
antibiogram- on the severity of the infection, if and where
it disseminated and the immune status of the patient.
The empiric gold standard of medical treatment is tri-
methoprim-sulfamethoxazole (TMP-SMX), which well
penetrates the cerebral barrier [24], but N. farcinica has a
high rate of resistance against TMP-SMX [6-9].
Amikacin, imipenem, third generation cephalosporins,
minocycline, netilmicin and amoxicillin-clavulanic acid
are second line antibiotics for nocardiosis [3]. There is a
characteristic resistance of N. farcinica to ampicillin,
broad-spectrum cephalosporine, clarithromycin and
aminoglycosides except amikacin. It is susceptible to cip-
rofloxacin, linezolid and imipenem [2].
Patients with disseminated disease, especially the CNS,
should be treated with a combined therapy including
TMP-SMX and a bactericidal agent or a combination of
imipenem and amikacin. Involvement of CNS might be
treated with third generation cephalosporins [22]. Further
medical treatment would be based on susceptibility
results. Therapy must start intravenously and can later be
replaced by oral therapy depending on clinical and radio-
logical responses. An alternative antibiotic drug for resist-
ant bacteria is linezolid [3].
The therapy has to be continued for several months
because of high relapse rates, depending on the immune
status of the patient. If CNS is involved, therapy must last
at least 12 months [14,25], followed by monitoring for at
least another year after completion of the therapy [26].
Patients with a persisting immunodeficiency should
receive a prolonged therapy and a low-dose prophylaxis
[27].
In addition to drug treatment a larger abdominal abscess
should be treated by drainage and/or radical excision.
Cerebral abscesses can be excised and this seems to lower
the mortality of the patient compared to solitary drug
treatment with or without aspiration/drainage, depending
on the size and growing behaviour over time [28].
Data about the prognosis are highly oscillating, mortality
rates between 14% and 40% have been published, in case
of dissemination even 100% [3]. Depending on the point
of diagnosis, the beginning of the treatment and the resist-
ance to antibiotics, as well as secondary host factors, the
mortality rate of cerebral abscesses may even be higher,
75% to 90% [29,30].
This case report presents the surprising diagnosis of an
adrenal abscess caused by Nocardia farcinica mimicking a
malignant adrenal mass and nicely demonstrates that pul-
monary Nocardia infections can easily be misdiagnosed,
because in the beginning there are only uncharacteristic
symptoms of acute, subacute or chronic pneumonia. Fur-
thermore, the case illustrates the difficulty to differentiate
between adrenal abscess, adrenal metastasis, necroticBMC Infectious Diseases 2009, 9:194 http://www.biomedcentral.com/1471-2334/9/194
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malignant tumour and complex adrenal cysts on CT [19],
although contrast CT is generally accepted as the corner-
stone of adrenal imaging [18].
Case presentation
Initial reason for hospitalization of the 71 year old female
patient in the department of internal medicine was an
atypical pneumonia with the symptoms of low-grade
fever and a cough without expectoration in combination
with a progredient adynamia, a reduced general condition
(40%, Karnofsky performance status scale), subtle nausea
and a lowered ability to concentrate in the last four weeks.
Relevant ancillary diagnoses were arterial hypertension,
cardiac insufficiency (NYHA II) and former alcohol addic-
tion without any evidence for a liver disease. Home med-
ication was an antihypertensive combination therapy
(Bisoprolol 5 mg and Hydrochlorothiazid/Ramipril 12.5/
5 mg).
Physical examination of the underweight patient (47 kg/
168 cm) revealed basal crackles on both lungs and low
fever (37.8°C). Neurologic status was without pathologic
findings.
Pathologic findings in basic diagnostic investigations
were a moderate leucocytosis (12.6/nl, normal value 4.0-
10.0/nl) and an elevated C-reactive protein (24,65 mg/l,
normal value <1.0). Differential count showed the follow-
ing results: Lymphocytes 12.9% (normal value 25-40%),
granulocytes 75.4% (55-75%), basophile granulocytes
0.2% (0.2-1.3%), eosinophile granulocytes 0.2% (0.8-
6.2%) monocytes 11.3% (2-8%). Thorax x-ray showed
diffuse small nodules and in some parts also confluent
infiltrations; pleural effusion on the left side (Figure 1).
A diagnosis of atypical pneumonia was established and an
empiric antibiotic treatment with gentamicin and ceftriax-
one was initiated. Under therapy febrile temperature and
abnormal laboratory values decreased in the following
days (Leucocytes 12.1/nl and CrP 7.3 mg/dl).
Initial examination included an abdominal ultrasound,
which showed a suspicious right-sided retrohepatic,
suprarenal incidentaloma.
The computed tomography (CT) of abdomen and thorax
showed a 6 cm large, central septed tumour in the right
adrenal gland with infiltration of the inferior Vena cava
and a 3-4 cm long intravenous thrombus inside. In addi-
tion, an infiltration of the hepatic and renal capsule as
well as the diaphragm was described (Figure 2). These
morphologic findings were highly suspicious of a malig-
nant tumour.
Furthermore, CT supported the diagnosis atypical pneu-
monia with parenchymal infiltrations in the whole lung
and partial nodular changes of the parenchyma with reac-
tive effusion. It showed enlarged bronchopulmonary,
hilar and mediastinal lymph nodes, which were inter-
preted as pneumonic inflammatory effects.
Because of the diagnosis of a malignant tumour the
patient was transferred to our surgical clinic after recover-
ing from pneumonia. At that time leucocytes and CrP had
nearly decreased to a physiologic level (10.4/nl and 2.83
mg/l).
To exclude an endocrine activity of the tumour, levels of
suprarenal hormones were determined in plasma and
urine, respectively (Metanephrine- and aldosterone-levels
in collected urine and dexamethasone suppression tests
were at a physiologic level).
We performed a radical in toto resection of the right adre-
nal gland. The intraoperative finding showed a dense
adrenal mass infiltrating the surrounding tissues so that a
tangential resection of the Vena cava inferior, diaphragm,
retroperitoneum and Gerota's fascia was performed. The
specimen was sent for pathological analysis.
A routine chest x-ray in the ICU one day after the opera-
tion showed recurrent pneumonic infiltrations. Endotra-
cheal aspirates were purulent and the material was sent for
microbiological analysis. An antibiotic treatment was
started with piperacillin/sulbactam.
Thorax x-ray with diffuse small nodules and in some parts  also confluent infiltrations; pleural effusion on the left side Figure 1
Thorax x-ray with diffuse small nodules and in some 
parts also confluent infiltrations; pleural effusion on 
the left side.BMC Infectious Diseases 2009, 9:194 http://www.biomedcentral.com/1471-2334/9/194
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On the third postoperative day the patient developed a
distal focussed hemiparesis of the left arm, without sensi-
tive deficiencies. On the very same day the preliminary
results of microbiological analysis of the culture of bron-
chioalveolar lavage (on non-selective culture media) were
reported as Nocardia species. Gram-stained culture has
revealed Gram-positive bacilli (Figure 3A). Few days later
N. farcinica was identified via sequencing of the eubakte-
rial 16s rRNA using polymerase chain reaction (PCR) as
described by Weisburg et al[31] Both strands of the ~500
bp PCR product were sequenced using the BigDye Termi-
nator Cycle Sequencing Kit (Applied Biosystems, USA),
and analyzed on an ABI PRISM 310 Genetic Analyser
(Applied Biosystems, USA). The sequence shows homol-
(A) Contrast-enhanced Coronal CT image of the abdomen shows a 6 cm large suprarenal, contrast enhancing tumour with  central septet necrosis (→) (B) Coronal image shows infiltration of the Vena cava inferior and inside a 3-4 cm long thrombus  (→) Figure 2
(A) Contrast-enhanced Coronal CT image of the abdomen shows a 6 cm large suprarenal, contrast enhancing 
tumour with central septet necrosis (→) (B) Coronal image shows infiltration of the Vena cava inferior and 
inside a 3-4 cm long thrombus (→). In addition an infiltration of the hepatic and renal capsule as well as the diaphragm is 
shown.
(A) Cultured Nocardia farcinica present as Gram-positive, beaded, thin, branching, Gram-positive rods (Kinyoun-staining, Origi- nal magnification ×1000) (B) Histological findings of the adrenal gland were a large necrotic and chronic putrid abscess forma- tion (→) (H&E-staining, Original magnification × 10) Figure 3
(A) Cultured Nocardia farcinica present as Gram-positive, beaded, thin, branching, Gram-positive rods 
(Kinyoun-staining, Original magnification ×1000) (B) Histological findings of the adrenal gland were a large 
necrotic and chronic putrid abscess formation (→) (H&E-staining, Original magnification × 10).BMC Infectious Diseases 2009, 9:194 http://www.biomedcentral.com/1471-2334/9/194
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ogy over 99,9% to the 16s rRNA gene of N. farcinica avail-
able at the National Center for Biotechnology
Information http://www.ncbi.nlm.nih.gov.
Histology of the adrenal gland revealed a necrotic and
chronic putrid abscess-formation (Figure 3B).
To rule out the neurological deficits an MRI of the brain
was performed, which indeed showed multiple abscess-
typical, circular contrast-enhancing supratentorial lesions
on both sides of the brain and even more lesions occipital
and left frontal, which corresponded to the neurologic
symptoms (Figure 4).
An aspiration or drainage was discussed, but because of
the size and multiplicity of cerebral abscesses neurosur-
geons favoured a non-invasive therapy.
We administered an intravenous antibiotic therapy with
imipenem/cilastatin and amikacin for three weeks and
later according to the susceptibility results we added tri-
methoprim-sulfamethoxazole (TMP-SMX) (good suscep-
tibility of TMP-SMX, imipenem, meropenem and
amikacin). Intravenous therapy was continued for six
weeks and after discharge an oral trimethoprim-sulfame-
thoxazole therapy was administered for another twelve
months.
Under pharmaceutical therapy and physiotherapy the
neurological status improved and the patient was trans-
ferred to a neurologic rehabilitation three weeks after the
operation.
In a follow-up cranial MRI six month later, the previously
detected foci had become smaller or had completely dis-
appeared.
Conclusion
Because of its low incidence nocardia infections are not
well known and are therefore very often not considered in
the initial diagnosis.
We recommend keeping nocardia infection in mind for
patients with atypical pneumonia unresponsive to empir-
ical broad-spectrum antibiosis even in previously healthy
patients, even more so if they have any suspicious tumour
and/or neurologic symptoms.
Delay of adequate antibiotic therapy can have serious
consequences.
Furthermore, this case shows the necessity to keep the
possibility of an adrenal abscess in mind as one of the dif-
ferential diagnosis for adrenal incidentaloma in the pres-
ence of such clinical and diagnostical findings.
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